Literature DB >> 26043703

Performance of a computerised visual acuity measurement device in subjects with age-related macular degeneration: comparison with gold standard ETDRS chart measurements.

Y Bokinni1, N Shah2, O Maguire2, D A H Laidlaw2.   

Abstract

PURPOSE: The aim of the study was to compare the performance of two different COMPlog computerised, single letter scoring, visual acuity (VA) measurements against gold standard Early Treatment Diabetic Retinopathy Study (ETDRS) chart measurements in patients with age-related macular degeneration (AMD). One computerised algorithm presented five and the other presented three letters per line; both computerised algorithms utilised half, rather than the full-letter width spacing standard on ETDRS charts that might induce crowding, fixation problems, increased test-retest variability (TRV), and bias.
METHODS: Fifty patients with AMD (mean age 83 years) underwent timed test and retest VA measurements using ETDRS charts and COMPlog five (C5) and three (C3) letters per line computerised VA measurement algorithms. All tests utilised single-letter scoring methodology. Bland and Altman methods were employed. Performance was measured in terms of bias, TRV, and test time.
RESULTS: The C5 and C3 scores showed no bias compared with the ETDRS chart measurements. C5 measurements had equal TRV to the ETDRS chart (±0.13 logMAR) with similar median test times (105 and 96 s, respectively). C3 measurements were slightly more variable (TRV ±0.17 logMAR), but 30 s quicker than ETDRS chart measurements.
CONCLUSIONS: The closer letter spacing employed in COMPlog testing algorithms appears to have no adverse effect on VA measurements compared with the gold standard ETDRS chart in patients with AMD. The three letter per line testing algorithm facilitates faster testing but with a two letter increase in TRV.

Entities:  

Mesh:

Year:  2015        PMID: 26043703      PMCID: PMC4541361          DOI: 10.1038/eye.2015.94

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  29 in total

1.  Modeling logMAR visual acuity scores: effects of termination rules and alternative forced-choice options.

Authors:  A Carkeet
Journal:  Optom Vis Sci       Date:  2001-07       Impact factor: 1.973

2.  Changing from Snellen to LogMAR: debate or delay?

Authors:  Badrul Hussain; George M Saleh; Sobha Sivaprasad; Christopher J Hammond
Journal:  Clin Exp Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 4.207

3.  Vistech VCTS 6500 charts--within- and between-session reliability.

Authors:  B C Reeves; J M Wood; A R Hill
Journal:  Optom Vis Sci       Date:  1991-09       Impact factor: 1.973

4.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

5.  Validation of printed and computerised crowded Kay picture logMAR tests against gold standard ETDRS acuity test chart measurements in adult and amblyopic paediatric subjects.

Authors:  N Shah; D A H Laidlaw; S Rashid; P Hysi
Journal:  Eye (Lond)       Date:  2011-12-23       Impact factor: 3.775

6.  Reliability of the electronic early treatment diabetic retinopathy study testing protocol in children 7 to <13 years old.

Authors:  Susan A Cotter; Raymond H Chu; Danielle L Chandler; Roy W Beck; Jonathan M Holmes; Melissa L Rice; Richard W Hertle; Eileen E Birch; Pamela S Moke
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

7.  A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study.

Authors:  Geeta A Lalwani; Philip J Rosenfeld; Anne E Fung; Sander R Dubovy; Stephen Michels; William Feuer; Janet L Davis; Harry W Flynn; Maria Esquiabro
Journal:  Am J Ophthalmol       Date:  2009-04-18       Impact factor: 5.258

8.  Visual acuity and fixation characteristics in age-related macular degeneration.

Authors:  Isabel Cacho; Christine M Dickinson; Barnaby C Reeves; Robert A Harper
Journal:  Optom Vis Sci       Date:  2007-06       Impact factor: 1.973

Review 9.  Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.

Authors:  J L Colquitt; J Jones; S C Tan; A Takeda; A J Clegg; A Price
Journal:  Health Technol Assess       Date:  2008-05       Impact factor: 4.014

10.  The use of accurate visual acuity measurements in clinical anti-cataract formulation trials.

Authors:  D B Elliott; M Sheridan
Journal:  Ophthalmic Physiol Opt       Date:  1988       Impact factor: 3.117

View more
  11 in total

1.  Comment on 'The Eye Phone Study: reliability and accuracy of assessing Snellen visual acuity using smartphone technology'.

Authors:  M Rodríguez-Vallejo
Journal:  Eye (Lond)       Date:  2015-09-11       Impact factor: 3.775

2.  The Test-Retest Variability of the COMPlog System in Participants with Induced Non-Normal Visual Acuity.

Authors:  Mun Wei Kan; Anne Bjerre
Journal:  Br Ir Orthopt J       Date:  2019-04-11

3.  Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy.

Authors:  Suman K Paine; Lakshmi K Mondal; Prasanta K Borah; Chandra K Bhattacharya; Jagadish Mahanta
Journal:  Mol Vis       Date:  2017-06-22       Impact factor: 2.367

Review 4.  Atropine Penalization Versus Occlusion Therapies for Unilateral Amblyopia after the Critical Period of Visual Development: A Systematic Review.

Authors:  Daniel C Osborne; Kathryn M Greenhalgh; Megan J E Evans; Jay E Self
Journal:  Ophthalmol Ther       Date:  2018-10-16

5.  Visual impairment in aging and cognitive decline: experience in a Memory Clinic.

Authors:  Marta Marquié; Miguel Castilla-Martí; Sergi Valero; Joan Martínez; Domingo Sánchez; Isabel Hernández; Maitée Rosende-Roca; Liliana Vargas; Ana Mauleón; Octavio Rodríguez-Gómez; Carla Abdelnour; Silvia Gil; Miguel A Santos-Santos; Montserrat Alegret; Ana Espinosa; Gemma Ortega; Alba Pérez-Cordón; Ángela Sanabria; Natalia Roberto; Sonia Moreno-Grau; Itziar de Rojas; Rafael Simó; Andreea Ciudin; Cristina Hernández; Adelina Orellana; Gemma Monté-Rubio; Alba Benaque; Agustín Ruiz; Lluís Tárraga; Mercè Boada
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.379

6.  Psychophysical Validation of a Novel Active Learning Approach for Measuring the Visual Acuity Behavioral Function.

Authors:  Yukai Zhao; Luis Andres Lesmes; Michael Dorr; Peter J Bex; Zhong-Lin Lu
Journal:  Transl Vis Sci Technol       Date:  2021-01-04       Impact factor: 3.283

7.  Association between retinal thickness and β-amyloid brain accumulation in individuals with subjective cognitive decline: Fundació ACE Healthy Brain Initiative.

Authors:  Marta Marquié; Sergi Valero; Miguel Castilla-Marti; Joan Martínez; Octavio Rodríguez-Gómez; Ángela Sanabria; Juan Pablo Tartari; Gemma C Monté-Rubio; Oscar Sotolongo-Grau; Montserrat Alegret; Alba Pérez-Cordón; Natalia Roberto; Itziar de Rojas; Sonia Moreno-Grau; Laura Montrreal; Isabel Hernández; Maitee Rosende-Roca; Ana Mauleón; Liliana Vargas; Carla Abdelnour; Silvia Gil; Ester Esteban-De Antonio; Ana Espinosa; Gemma Ortega; Francisco Lomeña; Javier Pavia; Assumpta Vivas; Miguel Ángel Tejero; Marta Gómez-Chiari; Rafael Simó; Andreea Ciudin; Cristina Hernández; Adelina Orellana; Alba Benaque; Agustín Ruiz; Lluís Tárraga; Mercè Boada
Journal:  Alzheimers Res Ther       Date:  2020-03-31       Impact factor: 6.982

8.  BIOFACE: A Prospective Study of Risk Factors, Cognition, and Biomarkers in a Cohort of Individuals with Early-Onset Mild Cognitive Impairment. Study Rationale and Research Protocols.

Authors:  Ester Esteban de Antonio; Alba Pérez-Cordón; Silvia Gil; Adelina Orellana; Amanda Cano; Montserrat Alegret; Ana Espinosa; Emilio Alarcón-Martín; Sergi Valero; Joan Martínez; Itziar de Rojas; Óscar Sotolongo-Grau; Elvira Martín; Assumpta Vivas; Marta Gomez-Chiari; Miguel Ángel Tejero; Mireia Bernuz; Lluis Tárraga; Agustín Ruiz; Marta Marquié; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

9.  Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.

Authors:  Timothy L Jackson; Catey Bunce; Riti Desai; Jost Hillenkamp; Chan Ning Lee; Noemi Lois; Tunde Peto; Barnaby C Reeves; David H Steel; Rhiannon T Edwards; Jan C van Meurs; Hatem Wafa; Yanzhong Wang
Journal:  Trials       Date:  2022-01-31       Impact factor: 2.279

10.  Can Visual Acuity Be Reliably Measured at Home? Validation of Telemedicine Remote Computerised Visual Acuity Measurements.

Authors:  Ailsa Ritchie; Silva Atamian; Nilpa Shah; Alistair Laidlaw; Christopher Hammond
Journal:  Br Ir Orthopt J       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.